Vontobel Holding Ltd. Bio Atla, Inc. Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 16,000 shares of BCAB stock, worth $27,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,000

Holding current value

$27,520

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$1.17 - $2.05 $18,720 - $32,800	16,000 New	16,000 $28,000
Q4 2023 Jun 03, 2024	SELL	$1.27 - $3.18 $11,598 - $29,042	-9,133 Reduced 1.28%	706,062 $1.74 Million
Q4 2023 Jan 29, 2024	SELL	$1.27 - $3.18 $11,598 - $29,042	-9,133 Reduced 1.28%	706,062 $1.74 Million
Q3 2023 Jun 03, 2024	BUY	$1.7 - $3.07 $254,224 - $459,100	149,544 Added 26.44%	715,195 $1.22 Million
Q3 2023 Oct 10, 2023	BUY	$1.7 - $3.07 $254,224 - $459,100	149,544 Added 26.44%	715,195 $1.22 Million
Q2 2023 Jun 03, 2024	BUY	$2.83 - $3.87 $38,230 - $52,279	13,509 Added 2.45%	565,651 $1.7 Million
Q2 2023 Jul 24, 2023	BUY	$2.83 - $3.87 $38,230 - $52,279	13,509 Added 2.45%	565,651 $1.7 Million
Q1 2023 Jun 03, 2024	BUY	$2.3 - $8.25 $1.27 Million - $4.56 Million	552,142 New	552,142 $1.48 Million
Q1 2023 Apr 12, 2023	BUY	$2.3 - $8.25 $930,844 - $3.34 Million	404,715 Added 274.52%	552,142 $1.48 Million
Q4 2022 Feb 14, 2023	BUY	$6.29 - $11.01 $927,315 - $1.62 Million	147,427 New	147,427 $1.22 Million

Others Institutions Holding BCAB

# of Institutions

Shares Held

17.3M

Call Options Held

500

Put Options Held

33.5K

Israel Englander Millennium Management LLC | New York, Ny

2.66M
Shares

$4.57 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

2.52M
Shares

$4.33 Million
0.38% of portfolio
Vanguard Group Inc Valley Forge, PA

1.89M
Shares

$3.24 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.86M
Shares

$3.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

874K
Shares

$1.5 Million
0.13% of portfolio

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account